Bristol-Myers Squibb buy Guggenheim
Start price
23.12.25
/
50%
€46.50
Target price
23.12.26
-
Performance (%)
1.92%
Price
02.02.26
€47.40
Summary
This prediction is currently active. The BUY prediction by Guggenheim shows slight gains of 1.92%. This prediction currently runs until 23.12.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | 3.156% | 3.156% |
| iShares Core DAX® | -0.436% | 1.181% |
| iShares Nasdaq 100 | 0.854% | 1.475% |
| iShares Nikkei 225® | 2.652% | 6.401% |
| iShares S&P 500 | 1.190% | 1.169% |
Comments by Guggenheim for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) had its "buy" rating reaffirmed by analysts at Guggenheim.
Ratings data for BMY provided by MarketBeat